FDA NDC Directory · JSON-LD · Markdown

Cyclobenzaprine Hydrochloride

NDC 68788-8522 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerPreferred Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091281
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsCYCLOBENZAPRINE HYDROCHLORIDE (15 mg/1)
Marketing started20230912
Package count1

External sources

Source: openFDA. Public-domain (CC0).